Clinical and histopathological observations suggest that the pathogenesis of cutaneous melanoma evolves through multiple stages . It has been proposed that early stages are characterized by benign proliferation of melanocytic cells and later stages by acquisition of competence for invasion and metastasis (1). The recognition that dysplastic nevi are a class of pigmented lesions with potential for malignant change is consistent with the existence of a precursor step in the development of melanoma (2). Phenotypic markers that discriminate normal melanocytes from melanoma cells would be particularly useful for dissecting stages in melanocyte transformation. However, definitive criteria that distinguish benign melanocytes from premalignant and malignant cells have not been established .
dissolved with 100 kl of 0 .3% hydrogen peroxide . Frozen normal kidney tissue sections served as positive controls for each experiment . Negative controls included 20 Fcg/ml of mouse IgGI mAb S1 .
Radioimmunoprecipitation. Cell labeling, immunoprecipitation, and gel electrophoresis were carried out as previously described (15) . Cells were labeled with [ 5 H ]glucosamine (New England Nuclear, Boston, MA) over 72 h in glucose-free Eagle's MEM containing 7 .5% dialyzed FCS, and cell extracts were prepared in NP-40 0 .5% (vol/vol), 10 mM Tris-HCI, pH 7 .4, and 150 mM NaCl . Lysates were radioimmunoprecipitated with mAb followed by 5 ng/ml protein A-Sepharose (Pharmacia Fine Chemicals), then reduced with dithiothreitol (Boehringer-Mannheim, Indianapolis, IN) ; immunoprecipitates were resolved by SDS-PAGE .
Binding Assays with Radiolabeled Antibody and Adenosine Deaminase. Bovine intestine adenosine deaminase was purchased from Calbiochem-Behring Corp . (La Jolla, CA) . Adenosine deaminase was further purified by fast-performance liquid chromatography (Pharmacia Fine Chemicals) with a Mono Q anion exchange column . The column was eluted with a salt gradient from 5 mM to 1 M NaCl in MES buffer (2-[N-morpholino] ethane-sulfonic acid) (Sigma Chemical Co .), 0 .05 M, pH 6 . Purified adenosine deaminase gave a single band of^-38 kD on SDS-PAGE stained by Coomassie blue . Purified adenosine deaminase and purified mAbs S23 and S27 were labeled with`251 (New England Nuclear) by the chloramine T method . Labeled protein was separated by a G50 fine Sephadex (Pharmacia Fine Chemicals) column . Radiolabeled adenosine deaminase was additionally dialyzed against PBS . The specific activity was 0 .5-1 .0 ACi/Pg for adenosine deaminase (>80% binding by absorption tests with cultured melanocytes) and 1-5 ACl/Ag for mAbs (>80% immunoreactive by absorption tests) . SDS-PAGE revealed a single protein band of ' 25 I-labeled adenosine deaminase (^-38 kD) and of mAbs (^-160 kD) under nonreducing conditions . Binding assays and RIAs were performed by incubating 10 5 target cells with radiolabeled adenosine deaminase or mAb in the presence or absence of >10-fold excess cold adenosine deaminase or mAb, respectively, for 2 h at 4°C . Cells were pelleted for 30 s, washed, and counted for cell number and for radioactivity in a gamma counter . Specific binding was determined from the following calculation : Specific binding = (bound radiolabeled protein in the absence of cold protein) -(bound radiolabeled protein in the absence of excess cold protein) . Nonspecific binding was <10% of total bound protein . Binding curves were determined by third order polynomial smoothing using Statgraphics software package (STSC, Inc ., Rockville, MD) .
Infection ofMelanocytes with Murine Sarcoma Virus. Viral stocks were isolated from NIH 3T3 nonproducer clones infected with Kirsten murine sarcoma virus (Ki-MSV) or Harvey murine sarcoma virus (Ha-MSV) and superinfected with 4070A amphotrophic murine leukemia virus (MuLV) (16) . Ki-MSV and Ha-MSV pseudotypes were harvested from 24-h cell-free supernatants and stored at -70°C . For infection, 105 melanocytes were treated for 60 min with DEAE/dextran (25 mg/ml), washed, and incubated with virus at a multiplicity of infection of 1 PFU/cell . Transforming activity of virus produced by infected melanocytes was determined by focus assays on NIH 3T3 cells (17) . Focus forming units per milliliter of supernatant fluid were 3 x 10 4 for Ha-MSV and 3 x 10 5 for Ki-MSV (16) . Cloning efficiency was determined by plating 105 cells in soft agar (0 .75% bottom layer and 0 .3% top layer) and scoring colonies of >50 cells at 2-3 wk .
In Vitro Transformation of Melanocytes. Two human newborn foreskin melanocyte cultures, FS 1190 and FS IOW, were transformed according to the following procedure . Before transformation, cell strains were maintained in melanocyte medium (7) as described above and were passaged at a regular interval of 3 weeks and at a ratio of 1 :3 . For induction of transformation, cell lines FS 1190, passage 15, and FS 10W, passage 29, were grown in complete medium containing PMA, cholera toxin and isobutylmethylxanthine (IBMX) 10 -5 M (18) . This supplemented medium induced rapid proliferation of melanocytes . Cultures were then passaged every 3 wk, and during the next 1-2 mo colonies of morphologically altered cells were observed . After 2 mo in PMA/cholera toxin/IBMXsupplemented medium, colonies were selected that grew in complete medium without PMA (PMA is the crucial mitogenic factor in melanocyte medium) (7) . After initial detected on the cell surface of 51 melanocyte cultures derived from fetal, newborn, and adult skin and adult choroid. Identical results were observed in assays using mAbs S6 and S23, which detect different epitopes on the ADAbp molecule . Fig Melanocytes, unlike cultured melanoma cells, require exogenous growth factors to proliferate in tissue culture. To demonstrate that ADAbp expression was not simply the result of induction by exogenous growth factors, melanocytes were established under different growth conditions and tested for expression of ADAbp (Fig . 2B ). ADAbp was equally expressed by melanocytes established in : (a) the phorbol ester PMA with or without cholera toxin, (b) cholera toxin alone (these cultures contained a mixture of keratinocytes and melanocytes, but melanocytes were easily distinguished by their morphology and pigmentation), (c) melanocyte growth factor derived from the fetal fibroblast cell line WI-38, and (d) melanocyte growth factor derived from the melanoma cell line SK-MEL-131 . Conversely, 18 melanoma cell lines grown in PMA with or without cholera toxin for periods of 1-3 mo remained ADAbp (data not shown) . Expression of ADAbp by melanocytes and lack of expression by melanomas were not related to rate of growth (doubling times ranged from 48 h to >120 h for melanocyte cultures and 20 h to >120 h for melanoma cultures) or degree of confluency in tissue culture. Melanocytes cultured in complete medium without growth factors stop proliferating within 5-7 d (7) . No change in ADAbp expression, determined by titers of mAbs S6, S23, and S27, was observed 5 and 7 d after removal of the growth factors PMA and cholera toxin from melanocyte cultures, suggesting that ADAbp expression was not strictly related to cell proliferation .
ADAbp was detected on the cell surface of newborn foreskin melanocytes by mixed hemadsorption assays as early as 4 d after explantation into tissue culture (Fig . 2C) . In these assays, pigmented, bipolar spindle-shaped melanocytes could easily be distinguished from other cell types, i.e ., fibroblasts and keratinocytes, in the culture. Freshly cultured melanocytes, at day 4 after explant, were observed to express lower levels of ADAbp than cultures at day 8 ( Fig. 2 C) . This low expression possibly is related to preparation of epidermal specimens in trypsin and EDTA for 18-24 h before placement in culture; cell surface ADAbp is removed by trypsin treatment (9) . No ADAbp expression was detected in freshly explanted melanoma cultures as early as day 2 in culture ( Fig . 2 C) .
ADAbp synthesis by melanocyte cultures was confirmed by radioimmunoprecipitation experiments using whole cell lysates of melanocytes metabolically labeled with [sH]glucosamine (Fig . 3) . The molecular size of ADAbp on melanocytes (120,000 mol wt) was identical to previously characterized ADAbp expressed by control renal cell carcinoma cell line SK-RC-1 (5, 9) . ADAbp (2) . Cultures of melanocytes derived from two dysplastic nevi and three giant congenital nevi were assayed for expression of ADAbp. Care was taken during preparation of nevus cultures to select dermal and epidermal areas within the specimen that contained nevus cells. Pigmented cells derived from giant congenital and dysplastic nevi expressed little or no ADAbp, with the exception of melanocytes derived from one congenital nevus specimen (Figs. 1 and 2D) . The decrease or loss of ADAbp expression was the only phenotypic trait that distinguished pigmented cells of dysplastic and congenital nevi from cultured melanocytes derived from normal skin . Otherwise, cultures from congenital and dysplastic nevi and normal skin were phenotypically comparable : cells remained dependent on growth factors for proliferation and expressed intermediate and late markers of melanocyte differentiation but not early markers; notably, melanocytes cultured from dysplastic and congenital nevi did not express class II major histocompatibility (Ia) antigens or epidermal growth factor receptor, which are traits expressed by a subset of melanomas (4).
Immunohistological Studies with mAb S27 in Formaldehyde-fixed Frozen Tissues. A limited panel of formaldehyde-fixed, frozen sections of normal skin, junctional nevi, dysplastic nevi, and primary and metastatic melanomas was examined for staining with mAb S27 (20 ug/ml) by indirect immunofluorescence and immunoperoxidase techniques . (Fig . 5) . There was detectable staining by mAb S27 of normal epidermal melanocytes in most specimens and of dermal fibroblasts in all specimens (Figs. 5 and 6 ) . Staining of normal fibroblasts by FIGURE 5 . Typing for ADAbp expression with mAb S27 on frozen tissue sections by immunofluorescence and immunoperoxidase techniques . Tissues were fixed with 3 .7% formaldehyde . (") Positive staining ; (O) no staining. mAbs against ADAbp has been reported previously (10) . No staining of epidermal melanocytes was observed in one specimen of palm skin (Fig. 5) . mAb S27 stained pigmented cells in two junctional nevi with a heterogeneous pattern (Figs. 5 and 6). No staining of two dysplastic nevi or a small panel of primary and metastatic melanomas was detected (Figs. 5 and 6). It was observed that normal appearing melanocytes in the epidermis at the borders of dysplastic nevi, primary melanoma specimens, and cutaneous metastases were stained with mAb 27 (data not shown) . These findings suggest that normal epidermal melanocytes in proximity to dysplastic nevi or primary melanomas have a normal phenotype and are not part of a field of premalignant or malignant cells.
Cultured Melanocytes Infected by Ha-MSV/Ki-MSV Continue to Express
ADAbp. The relationship of malignant transformation and regulation of ADAbp on melanocytic cells was investigated further by infecting melanocytes with transforming amphotropic pseudotypes of Ha-MSV or Ki-MSV. Ha-MSV and Ki-MSV contain activated oncogenes of the ras family . In a previous report we have shown that infection of normal cultured human melanocytes with Ki-MSV or Ha-MSV, but not control amphotropic MuLV helper virus, led to induction of certain phenotypic traits of melanoma cells (16) , including: (a) morphologic alterations characterized by clustering and piling up of cells, (b) increased growth rate and saturation density, (c) anchorage-independent growth with cloning frequencies in soft agar ranging from 0.04-0.1 %, (d) induction of class II major histocompatibility (Ia) antigens, and (e) augmentation of cell surface expression of the disialoganglioside GD3 (16) . Expression of la antigens and prominent expression of GD3 ganglioside are characteristics of melanoma cells. Despite these changes, melanocytes expressing activated ras remained dependent on exogenous growth factors for proliferation and were diploid at early passage (with some hyperdiploid cells at later passages), without any detectable chromosomal alterations or rearrangements . Infection with Ki-MSV and Ha-MSV did not induce any detectable change in the expression of ADAbp by melanocytes (16) (Fig. 2E) . These results indicate that downregulation of ADAbp expression is not tightly regulated with other ras-induced transformation traits in melanocytes. characteristics of transformed cells (16) , loss of ADAbp expression was not observed . During investigations of conditions that control growth of melanocytes, a novel system to transform human melanocytes was found (Eisinger, M. E., O . Marko, A. N. Houghton, manuscript in preparation) . Transformed colonies were observed in rapidly dividing cultures of two independent melanocyte cell lines, FS 1190 and FS 10W, derived from newborn foreskin . To elicit rapidly proliferating cells, cultures were grown in PMA, cholera toxin, and IBMX (18), and transformed-appearing colonies appeared after 1-2 mo . Transformed colonies had the following characteristics consistent with malignancy : (a) growth in complete medium without addition of exogenous growth factors, (b) spindle and polygonal-shaped cells with nuclear atypia and a high nuclear/cytoplasmic ratio, (c) high saturation density, (d) formation of colonies in soft agar, and (e) aneuploid karyotype. On the other hand, the parental newborn foreskin melanocyte cell lines FS 1190 and FS I OW were dependent on exogenous factors for growth, had a dendritic, bipolar-spindle morphology, grew at a low saturation density, were unable to grow in soft agar, and had a diploid karyotype. Transformation of FS 1190 and FS 10W cells was associated with loss of detectable ADAbp expression. Parental FS 1190 and FS I OW cultures expressed levels of ADAbp that were typical of other melanocyte cultures but transformants of FS 1190 and FS 1 OW were ADAbp- (Fig. 2F ). This transformation system confirms that ADAbp expression can be regulated during the process of melanocyte transformation. Discussion A constellation of phenotypic traits distinguishes transformed cells from their normal cell counterparts . Malignant cells characteristically acquire an altered morphology and appearance, grow in an anchorage-independent fashion, require lower amounts of exogenous growth factors, and have an abnormal karyotype. Despite these profound alterations, analysis of tumor cells has demonstrated that malignant transformation generates mainly quantitative changes in expression of cell components (i.e., increase or decrease) or modification of existing components (e.g., posttranslational modification) rather than qualitative changes (i.e., presence or absence) (20) . The subtle nature of critical phenotypic alterations is demonstrated in certain cell systems where regulation of a single protein can lead to transformation (21, 22) . In our studies of determinants detected by mAbs S6, S23, and S27, ADAbp was strongly expressed on melanocytes but was not detected on melanoma cells. These findings suggest that expression of ADAbp may differ qualitatively between melanocytes and melanoma cells . However, this presumption is limited by the sensitivity and specificity of the assays used to measure ADAbp, and therefore it is possible that small numbers of ADAbp molecules on melanoma cells are not detected or that only some determinants on the ADAbp molecule are regulated during transformation .
Loss of Expression of Adenosine
Lack of staining of melanocytes in occasional skin specimens could be related to an ADAbp phenotype (for instance in palm skin that may contain hyperproliferative epidermal cells) or to insufficient sensitivity of immunostaining techniques . In tests against cultured melanocytes fixed with 3 .7% formaldehyde, mAb S27 gave only weak to moderate staining by indirect immunofluorescence techniques (titers of 1/200 to 1/3,200), indicating that immunostaining techniques were not nearly as sensitive as mixed hemadsorption assays (titers 1/105 to 1/10 6) to detect ADAbp expression . In addition, epidermal melanocytes can be difficult to evaluate by immunostaining methods because they comprise only a small proportion of cells in the basal layer of the epidermis, they have endogenous peroxidase activity that can interfere with peroxidase-mediated staining, and they have pigment that can quench immunofluorescence staining .
Clark and coworkers (1) have proposed five "lesional steps" in the progression from melanocyte to melanoma : (a) pigmented cells that are regulated and restrained by a differentiation program, (b) dysplastic pigmented cells, (c) primary melanoma cells without competence for metastases, (d) primary melanoma cells with competence for metastases, and (e) metastatic melanoma cells. In relation to this scheme, normal melanocytes were ADAbp+, dysplastic nevi expressed little or no ADAbp, and primary and metastatic melanoma cells were ADAbp-. These data suggest that ADAbp expression decreases at a relatively early stage in the pathogenesis of melanoma, coinciding with the appearance of cytologic atypic (dysplastic nevi) and before acquisition of autonomous growth and invasiveness (primary melanoma). Studies of melanocyte transformation using culture systems also suggest an association between genetic alterations and ADAbp expression . Analysis of cultured melanocyte cells that corresponded to presumed early stages of transformation (e.g., melanocytes expressing activated ras genes and cells derived from dysplastic nevi) showed that downregulation of ADAbp on melanocytes is not coregulated with certain growth-related traits of malignant melanocytes, specifically anchorage-independent growth or growth factor-independent proliferation . One possibility is that chromosomal instability is closely linked to loss of ADAbp expression, particularly since karyotypic abnormalities can be observed in some melanocytes from dysplastic nevi and in most primary and metastatic melanoma cells (23, 24) . Further in vitro studies to dissect stages of melanocyte transformation will be necessary to test this possibility.
Other markers have been proposed to distinguish "lesional steps." Certain phenotypic traits of melanocyte cells derived from normal skin, nevi, primary melanoma, and metastases have been examined in detail by Herlyn et al. (25, 26) according to Clark's model of tumor progression (1) . Substantial alteration in ganglioside pattern and changes in expression of several antigens have been found that distinguish melanocytes derived from different lesional steps. Immunohistological techniques also have been used to describe a number of antigens that distinguish melanomas from benign nevi (27) (28) (29) (30) (31) (32) . According to serological specificity and molecular size, none of these antigens appear to correspond to ADAbp.
ADAbp is expressed by other cell lineages in addition to melanocytes (10, 33, 34) . A relationship between ADAbp expression and malignancy was first suggested in studies evaluating isoenzyme expression in normal and malignant tissues (35) . Decreases in ADAbp expression have been described in certain epithelial cancers including colon and kidney carcinomas, and in virally transformed fibroblasts (36) (37) (38) . In the case of colon carcinomas, more detailed studies have demonstrated both increased and decreased ADAbp expression in tumors compared to normal colon mucosa (39) (40) . Immunohistological studies have shown a correlation between increased ADAbp expression and differentiation state of the tumor, suggesting that ADAbp is regulated as part of the differentiation program of normal colon epithelium (39) (40) . However, within the melanocyte lineage there was no apparent association between ADAbp expression and stage of differentiation, consistent with the notion that ADAbp is expressed in the normal melanocyte lineage but is specifically downregulated as part of a transformation process. Expression of ADAbp can be contrasted with another set of cell surface glycoproteins, la antigens, that are regulated by both transformation and differentiation in melanocytes (4). We have found that la can be induced in melanocytes by viral ras gene products (16) and by melanocyte transformation in vitro (Eisinger, M ., L. J . Davis, and A. N . Houghton, unpublished observation) and additionally that la can be regulated in cloned melanoma cell lines as part of the melanocyte differentiation program (4) .
Although ADAbp is known to bind adenosine deaminase (19) , the function of the binding protein itself is unknown. Adenosine deaminase catalyzes irreversible deamination of adenosine to inosine and deoxyadenosine to deoxyinosine, and binding to ADAbp does not seem to affect the activity of the enzyme (19, 33) . Unlike many cell surface receptors, evidence suggests that ADAbp does not transport adenosine deaminase into cells but rather holds the enzyme at the cell surface (41) . One possibility is that loss of ADAbp could allow transformed melanocytes to become susceptible to inductive effects of adenosine. Studies to evaluate the possible role of adenosine on melanocytes' growth and differentiation are underway . ADAbp could influence intracellular events, for instance DNA replication or repair through effects on purine metabolism . According to either of these possibilities, the loss of expression of ADAbp by melanoma cells would directly influence the transformed phenotype, perhaps through regulation of cell growth or error-prone synthesis and repair of DNA. On the other hand, loss of ADAbp expression may be a secondary event, and therefore a consequence of changes in growth or differentiation of malignant cells. In either case, welldefined markers that distinguish melanocytes from melanoma cells will facilitate investigations of melanocyte transformation in vitro and in vivo .
Summary
It has been proposed that the pathogenesis of melanoma proceeds through multiple stages, ranging from benign proliferation of melanocytic cells to acquisition of the capacity to invade tissues and metastasize. During investigations of cell surface antigens expressed by melanocytes and melanoma, we identified an antigen system that was expressed by cultured normal melanocytes but not by melanoma cell lines. mAbs against this antigen detected a 120-kD cell surface glycoprotein on melanocytes. This molecule had been identified previously as the binding protein for adenosine deaminase (ADAbp). ADAbp was expressed by 51 melanocyte cell lines derived from normal fetal, newborn, and adult skin and adult choroid, but not by 102 melanoma cell lines derived from primary and metastatic lesions. Studies with radiolabeled bovine adenosine deaminase confirmed that melanocytes expressed binding sites for adenosine deaminase, but no binding sites were detected on cultured melanoma cells . Further studies showed that ADAbp+ melanocytes became ADAbp-upon malignant transformation in vitro. Immunohistochemical studies on a panel of frozen tissues demonstrated reactivity of anti-ADAbp mAbs with epidermal melanocytes and benign junctional nevi, but not with potentially premalignant dysplastic nevi or primary/metastatic melanoma lesions. These studies demonstrate that ADAbp expression is lost with malignant transformation of melanocytes, presumably at an early stage in the transformation process.
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